RAVAROTTO, VERDIANA
 Distribuzione geografica
Continente #
NA - Nord America 3.599
AS - Asia 2.510
EU - Europa 887
AF - Africa 341
SA - Sud America 310
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 8
Totale 7.689
Nazione #
US - Stati Uniti d'America 3.402
VN - Vietnam 685
SG - Singapore 653
CN - Cina 429
HK - Hong Kong 209
BR - Brasile 196
IT - Italia 143
DE - Germania 101
FR - Francia 83
IN - India 68
FI - Finlandia 66
SE - Svezia 60
TR - Turchia 47
BJ - Benin 38
GB - Regno Unito 38
IQ - Iraq 38
NL - Olanda 35
BD - Bangladesh 34
CA - Canada 30
JP - Giappone 29
PH - Filippine 27
RU - Federazione Russa 25
AR - Argentina 22
MX - Messico 22
PL - Polonia 22
SI - Slovenia 22
ZA - Sudafrica 21
SA - Arabia Saudita 20
AT - Austria 19
MY - Malesia 18
ES - Italia 17
TN - Tunisia 17
UA - Ucraina 17
UZ - Uzbekistan 17
AL - Albania 16
AZ - Azerbaigian 16
CH - Svizzera 16
CY - Cipro 15
JO - Giordania 15
MA - Marocco 15
CO - Colombia 14
EC - Ecuador 14
ID - Indonesia 14
MK - Macedonia 14
PT - Portogallo 14
RS - Serbia 14
BO - Bolivia 13
PA - Panama 13
VE - Venezuela 13
HT - Haiti 12
AU - Australia 11
BB - Barbados 11
BE - Belgio 11
CZ - Repubblica Ceca 11
GH - Ghana 11
GN - Guinea 11
GT - Guatemala 11
IR - Iran 11
KE - Kenya 11
KR - Corea 11
LB - Libano 11
PK - Pakistan 11
YT - Mayotte 11
AE - Emirati Arabi Uniti 10
BA - Bosnia-Erzegovina 10
DO - Repubblica Dominicana 10
IL - Israele 10
ML - Mali 10
MN - Mongolia 10
MU - Mauritius 10
NI - Nicaragua 10
PS - Palestinian Territory 10
RE - Reunion 10
SO - Somalia 10
UY - Uruguay 10
IE - Irlanda 9
JM - Giamaica 9
KZ - Kazakistan 9
LT - Lituania 9
MD - Moldavia 9
MG - Madagascar 9
SN - Senegal 9
TH - Thailandia 9
AO - Angola 8
BG - Bulgaria 8
BY - Bielorussia 8
CG - Congo 8
CU - Cuba 8
DK - Danimarca 8
EE - Estonia 8
GF - Guiana Francese 8
IS - Islanda 8
LC - Santa Lucia 8
LU - Lussemburgo 8
LV - Lettonia 8
ME - Montenegro 8
NE - Niger 8
PR - Porto Rico 8
PY - Paraguay 8
TJ - Tagikistan 8
Totale 7.369
Città #
San Jose 461
Fairfield 433
Ashburn 403
Singapore 391
Chandler 316
Ho Chi Minh City 211
Woodbridge 186
Hong Kong 183
Hanoi 161
Cambridge 145
Seattle 139
Beijing 127
Houston 118
Wilmington 117
Ann Arbor 92
Santa Clara 76
Boardman 58
Los Angeles 54
Da Nang 48
Helsinki 43
Munich 40
Padova 40
New York 38
San Diego 37
Cotonou 36
Haiphong 35
Lauterbourg 35
Medford 34
Princeton 34
Des Moines 33
Council Bluffs 32
São Paulo 32
Chicago 23
Istanbul 20
Amsterdam 19
Nanjing 19
Tashkent 17
Tokyo 17
Baghdad 15
Amman 14
Baku 14
Dong Ket 14
Roxbury 14
Turku 14
Buffalo 13
Chennai 13
Guangzhou 13
Hefei 13
Montreal 13
Ninh Bình 13
Panama City 13
Vienna 13
Hải Dương 12
Atlanta 11
Jinan 11
Bamako 10
Bridgetown 10
Brooklyn 10
Can Tho 10
Conakry 10
Frankfurt am Main 10
Nairobi 10
Orem 10
Phoenix 10
Tirana 10
Tân Tiến 10
Bytom 9
Bến Tre 9
Dakar 9
Johannesburg 9
Riyadh 9
Ulan Bator 9
Warsaw 9
Antananarivo 8
Belgrade 8
Bắc Ninh 8
Dublin 8
Dushanbe 8
Havana 8
Jeddah 8
Limassol 8
Luanda 8
Mamoudzou 8
Managua 8
Nanchang 8
New Delhi 8
Nha Trang 8
Niamey 8
Poplar 8
Shanghai 8
Stockholm 8
Thái Bình 8
Accra 7
Biên Hòa 7
Castries 7
Cayenne 7
Dallas 7
Montevideo 7
Nouakchott 7
Podgorica 7
Totale 4.907
Nome #
Pathophysiology of Post Transplant Hypertension in Kidney Transplant: Focus on Calcineurin Inhibitors Induced Oxidative Stress and Renal Sodium Retention and Implications with RhoA/Rho Kinase Pathway 308
Searching for an additional treatment to slowing the progression of Fabry disease 307
Oxidative stress - chronic kidney disease - cardiovascular disease: A vicious circle 285
Oxidative Stress and Cardiovascular-Renal Damage in Fabry Disease: Is There Room for a Pathophysiological Involvement? 270
Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients 258
Is heme oxygenase-1 turning out to be a key positive regulator for oxidative stress? 256
The Pivotal Role of Oxidative Stress in the Pathophysiology of Cardiovascular-Renal Remodeling in Kidney Disease 253
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 248
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 239
Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism. 233
Comment on “Vitamin E supplementation improves high-density lipoprotein and endothelial functions in end-stage kidney disease patients undergoing hemodialysis” by Mune et al. Clinical Nephrology DOI 10.5414/CN109197 e-pub: April 9, 2018 230
ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes 220
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 218
The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes. 215
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 214
ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements 214
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 204
Bartter's and Gitelman's syndromes 204
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 203
SP021CARDIOVASCULAR-RENAL REMODELING IN FABRY DISEASE: POSSIBLE INVOLVEMENT OF OXIDATIVE STRESS. A MOLECULAR BIOLOGY APPROACH 199
The importance of chronic magnesium deficiency in human disease and the Gitelman’s syndrome paradox 199
Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach 193
The Effect of Green Tea as an Adjuvant to Enzyme Replacement Therapy on Oxidative Stress in Fabry Disease: A Pilot Study 192
Rho kinase activity and atrial fibrillation: insights fromchronic kidney disease and dialysis patients. 192
Molecular biology based assessment of green tea effects on oxidative stress and cardiac remodelling in dialysis patients. 178
Molecular Characterization of A Novel Mutation In The Renal NaCl Cotransporter Causing Gitelman'€™s Syndrome By Impairing Transporter Trafficking 178
Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications. 177
Gitelman's Syndrome: characterization of a novel c.1181G>A point mutation and functional classification of the known mutations. 172
Tracing Angiotensin II's Yin -Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II. 169
Could nutritional therapy take us further in our approaches to Fabry disease? 162
Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension. 156
Gitelman’s and Bartter’s syndromes: from genetics to the molecular basis of hypertension and more. 153
The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes 150
Reduced oxidative stress in ADPKD patients treated with tolvaptan. 150
Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more. 141
Pathomechanism of oxidative stress in cardiovascularrenal remodeling and therapeutic strategies. 134
Molecular aspects of the altered Angiotensin II signaling in Gitelman’s syndrome 127
Relationship between NOX4 level and angiotensin II signaling in Gitelman's syndrome. Implications with hypertension. 86
null 50
Totale 7.737
Categoria #
all - tutte 21.932
article - articoli 19.677
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.055
Totale 42.664


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202198 0 0 0 0 0 0 0 0 0 0 30 68
2021/2022480 22 44 34 32 24 52 30 38 30 20 34 120
2022/2023537 87 68 40 78 79 62 2 35 55 0 26 5
2023/2024276 12 25 23 22 26 54 37 15 14 11 19 18
2024/2025906 7 54 32 45 96 34 51 94 41 44 150 258
2025/20264.175 245 277 487 602 377 189 989 296 445 213 55 0
Totale 7.737